NAGLU

RGD1564228; N-Acetyl-Alpha-Glucosaminidase

Predicted to enable alpha-N-acetylglucosaminidase activity. Predicted to be involved in heparan sulfate proteoglycan catabolic process. Predicted to act upstream of or within several processes, including circulatory system development; nervous system development; and proteoglycan metabolic process. Predicted to be located in extracellular exosome. Predicted to be active in lysosomal lumen. Human ortholog(s) of this gene implicated in Charcot-Marie-Tooth disease axonal type 2V; mucopolysaccharidosis III; and mucopolysaccharidosis type IIIB. Orthologous to human NAGLU (N-acetyl-alpha-glucosaminidase).